This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Biotie Therapies Corporation. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Yvonne Nymalm-Rejström: Innovator in Vascular Adhesion Protein Research
Introduction
Yvonne Nymalm-Rejström is a prominent inventor based in Turku, Finland. She has made significant contributions to the field of vascular adhesion proteins, particularly through her innovative research and patenting efforts.
Latest Patents
Yvonne holds a patent for "Crystalline VAP-1 and uses thereof." This invention relates to crystalline vascular adhesion protein-1 (VAP-1) and focuses on methods for utilizing structural information of crystalline human VAP-1 for the identification, design, and production of ligands and inhibitors. The patent also includes screening assays for the detection of these compounds, as well as inhibitors identified through the assays.
Career Highlights
Yvonne is associated with Biotie Therapies Corporation, where she has been instrumental in advancing research related to vascular adhesion proteins. Her work has contributed to a deeper understanding of the structural aspects of VAP-1 and its potential applications in medical science.
Collaborations
Some of her notable coworkers include Tommi Nyrönen and Tomi Airenne, who have collaborated with her on various projects within the company.
Conclusion
Yvonne Nymalm-Rejström's innovative work in the field of vascular adhesion proteins exemplifies the impact of research and patenting in advancing medical science. Her contributions continue to pave the way for future discoveries and applications in this important area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile